☆ 4.7 Article

Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling

FRONTIERS IN PHARMACOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

An efficient genotyper and star-allele caller for pharmacogenomics

Ananth Hari et al.

Summary: High-throughput sequencing is a powerful tool for determining genotypes of clinically important pharmacogenes, but accurately calling star-alleles is challenging. Aldy 4 is introduced as a fast and efficient tool for genotyping pharmacogenes, utilizing combinatorial optimization and improved models for accurate star-allele calling across different sequencing technologies. Comparison with other state-of-the-art callers demonstrates that Aldy 4 is the most accurate, making it an invaluable tool in the clinical toolbox.

GENOME RESEARCH (2023)

Add to Collection

Article Medicine, General & Internal

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J Swen et al.

LANCET (2023)

Add to Collection

Article Biotechnology & Applied Microbiology

Dynamic, adaptive sampling during nanopore sequencing using Bayesian experimental design

Lukas Weilguny et al.

Summary: BOSS-RUNS is an algorithmic framework and software that dynamically updates decision strategies based on real-time updates of uncertainty at each genome position. It optimizes information gain by deciding whether to fully sequence each DNA fragment, leading to improved variant calling in microbial communities.

NATURE BIOTECHNOLOGY (2023)

Add to Collection

Article Pharmacology & Pharmacy

PAnno: A pharmacogenomics annotation tool for clinical genomic testing

Yaqing Liu et al.

Summary: An automated Pharmacogenomics Annotation tool (PAnno) was developed to provide prescribing recommendations and phenotypes based on NGS data. It introduced a ranking model for inferring diplotypes and validated its performance using consensus data. PAnno also proposed an annotation method to classify drugs and predict specific drug phenotypes based on the Clinical Pharmacogenetics Implementation Consortium (CPIC) recommendations and the Pharmacogenomics Knowledgebase (PharmGKB). It provides an end-to-end solution for clinical pharmacogenomics decision support.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

A draft human pangenome reference

Wen-Wei Liao et al.

NATURE (2023)

Add to Collection

Article Pharmacology & Pharmacy

From gene to dose: Long-read sequencing and -allele tools to refine phenotype predictions of CYP2C19

Lonneke J. Graansma et al.

Summary: Genetic variations can lead to inter-individual differences in drug response. Current methods for clinical pharmacogenomic testing are limited in detecting all genetic variability in pharmacogenes. Long-read sequencing provides a valuable tool for characterizing specific gene regions and identifying novel haplotypes, potentially improving drug response prediction and therapy outcomes.

FRONTIERS IN PHARMACOLOGY (2023)

Add to Collection

Article Genetics & Heredity

A framework for real-time monitoring, analysis and adaptive sampling of viral amplicon nanopore sequencing

Rory Munro et al.

Summary: The SARS-CoV-2 pandemic highlights the importance of real-time sequence analysis for pathogen monitoring and surveillance. To ensure cost-effective sequencing, PCR amplification and barcoding are used to multiplex samples onto a single flow cell. However, maximizing and balancing coverage for each sample poses challenges. To address this, a real-time analysis pipeline called MinoTour was developed, which incorporates the ARTIC network bioinformatics analysis pipelines. Another tool, SwordFish, automates adaptive sampling on Nanopore sequencers during the sequencing run. These approaches improve coverage and reduce sequencing time and costs without affecting the consensus sequence.

FRONTIERS IN GENETICS (2023)

Add to Collection

Article Oncology

Computational pharmacogenotype extraction from clinical next-generation sequencing

Tyler Shugg et al.

Summary: This study assessed the accuracy of the Aldy computational method in extracting pharmacogenomics genotypes from whole genome sequencing (WGS) and whole exome sequencing (WES) data. The results showed that Aldy achieved over 99% accuracy in calling diplotypes for major pharmacogenes from both WGS and WES data, supporting its importance in clinical applications.

FRONTIERS IN ONCOLOGY (2023)

Add to Collection

Article Genetics & Heredity

Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)

Marwan K. Tayeh et al.

Summary: Pharmacogenomic testing analyzes genetic variants related to interindividual drug response variability, in order to predict drug response phenotype and guide medication management. Unlike inherited disease genetics, pharmacogenomics focuses on drug-dependent response phenotypes that may go unnoticed until unexpected reactions or treatment failures occur. This article provides laboratories with resources and best practices for the development and implementation of clinical pharmacogenomic testing.

GENETICS IN MEDICINE (2022)

Add to Collection

Article Pathology

CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype AnalysisA GeT-RM Collaborative Project

Andrea Gaedigk et al.

Summary: This study demonstrates the utility of NGS for pharmacogenetic testing and reveals the presence of many undiscovered novel alleles.

JOURNAL OF MOLECULAR DIAGNOSTICS (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

Curated variation benchmarks for challenging medically relevant autosomal genes

Justin Wagner et al.

Summary: The repetitive and complex nature of medically relevant genes poses challenges for accurate analysis, but a haplotype-resolved whole-genome assembly can help overcome these challenges. By characterizing 273 challenging genes, a curated benchmark set is obtained, which reports a large number of gene variations and can improve the accuracy of variant detection.

NATURE BIOTECHNOLOGY (2022)

Add to Collection

Article Genetics & Heredity

Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle

Maaike van der Lee et al.

Summary: The use of long-read sequencing has shown promise in resolving complex pharmacogenes and improving variant calling accuracy, with high recall and precision rates for SNVs and Indels. This technology has the potential to advance the understanding of gene-drug interactions and haplotype phasing in clinical practice.

PHARMACOGENOMICS JOURNAL (2022)

Add to Collection

Article Multidisciplinary Sciences

Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing

Igor Stevanovski et al.

Summary: This article describes a method for genotyping neurological STR expansions using targeted long-read sequencing with Oxford Nanopore's ReadUntil function. The method allows for accurate DNA analysis and haplotype-resolved assembly, and successfully diagnoses patients with neurogenetic diseases. Long-read sequencing solves large and complex STR expansions and reveals a diversity of STR alleles.

SCIENCE ADVANCES (2022)

Add to Collection

Article Biochemical Research Methods

ReadBouncer: precise and scalable adaptive sampling for nanopore sequencing

Jens-Uwe Ulrich et al.

Summary: This article presents a new approach for nanopore adaptive sampling that combines fast CPU and GPU base calling with read classification based on Interleaved Bloom Filters. It improves the potential enrichment of low abundance sequences and outperforms existing tools in the field.

BIOINFORMATICS (2022)

Add to Collection

Article Multidisciplinary Sciences

ClinPharmSeq: A targeted sequencing panel for clinical pharmacogenetics implementation

Seung-been Lee et al.

PLoS One (2022)

Add to Collection

Article Biochemistry & Molecular Biology

High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios

Marta Byrska-Bishop et al.

Summary: The 1000 Genomes Project is the largest open resource of whole-genome sequencing data, and a new high-coverage WGS 1kGP resource has been released, improving the sensitivity and accuracy of variant calls and making it more valuable for association studies.

CELL (2022)

Add to Collection

Article Genetics & Heredity

Long-read HiFi sequencing of NUDT15: Phased full-gene haplotyping and pharmacogenomic allele discovery

Erick R. Scott et al.

Summary: In this study, a novel long-read single-molecule real-time sequencing method was developed to comprehensively analyze the phase of NUDT15 sequence variants and perform star (*) allele diplotyping. The method showed robustness and accuracy compared to short-read genome sequencing, and it successfully phased all variants across the NUDT15 amplicons, including the identification of novel alleles. This innovative method has the potential to improve NUDT15 pharmacogenomic testing and phenotype prediction.

HUMAN MUTATION (2022)

Add to Collection

Review Pharmacology & Pharmacy

Challenges and opportunities associated with rare-variant pharmacogenomics br

Yitian Zhou et al.

Summary: Recent advances in NGS have identified thousands of rare pharmacogenetic variations with unknown functional effects, but accurate interpretation at the individual patient level remains challenging. Strategies involving experimental assays, AI, and machine learning combined with population-scale biobank projects can facilitate the interpretation of NGS data for personalized medicine.

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

Add to Collection

Article Genetics & Heredity

Cas9 targeted nanopore sequencing with enhanced variant calling improves CYP2D6-CYP2D7 hybrid allele genotyping

Kaat Rubben et al.

Summary: CYP2D6 is a crucial pharmacogene responsible for metabolizing or activating a significant portion of clinically used drugs. However, genotyping this gene is challenging due to its high similarity with neighboring pseudogenes and frequent formation of CYP2D6-CYP2D7 hybrids. In this study, a genotyping assay was developed using the nCATS-CoLoRGen pipeline, which accurately determines the complete sequence of CYP2D6-CYP2D7 and improves gene function prediction.

PLOS GENETICS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics

Joel A. Morales-Rosado et al.

Summary: NGS technology identified mutations in the CYP2C19 gene, particularly in cases of stent thrombosis. Functional studies revealed mutations causing abnormal protein expression and potentially leading to loss of function of CYP2C19 in ST cases.

CARDIOVASCULAR DRUGS AND THERAPY (2021)

Add to Collection

Article Genetics & Heredity

Determination of novel CYP2D6 haplotype using the targeted sequencing followed by the long-read sequencing and the functional characterization in the Japanese population

Koya Fukunaga et al.

Summary: NGS technology was used to identify novel CYP2D6 variants in the Japanese population, with in vitro metabolic studies used to predict CYP2D6 phenotype. The study identified 14 CYP2D6 variants not previously registered in the database, with 10 novel haplotypes registered. Based on metabolic activity, several alleles were predicted to be nonfunctional, and individuals were designated as normal, intermediate, or poor metabolizers. This research provides valuable insights into the effects of different CYP2D6 haplotypes on in vitro metabolic activities.

JOURNAL OF HUMAN GENETICS (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Readfish enables targeted nanopore sequencing of gigabase-sized genomes

Alexander Payne et al.

Summary: Nanopore sequencers selectively sequence DNA molecules by reversing voltage, overcome computational limitations with GPU base-calling, enrich specific chromosomes and genes, and enable efficient screening of target gene panels without specialized sample preparation.

NATURE BIOTECHNOLOGY (2021)

Add to Collection

Article Genetics & Heredity

Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data

Xiao Chen et al.

Summary: CYP2D6, responsible for metabolizing around 21% of clinically used drugs, is a critical component in personalized medicine initiatives. A new bioinformatics method called Cyrius has been developed to accurately genotype CYP2D6 using whole-genome sequencing data, showing superior performance compared to existing methods. Through improvements, Cyrius's accuracy has been increased to 99.3%, making it an important tool for integrating pharmacogenomics in WGS-based precision medicine initiatives.

PHARMACOGENOMICS JOURNAL (2021)

Add to Collection

Article Pharmacology & Pharmacy

An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine

Michelle Whirl-Carrillo et al.

Summary: Clinical annotations in PharmGKB summarize the association between variant-drug pairs and are assigned a level of evidence. To ensure consistency and transparency, a scoring system has been developed to automate LOE assignment. This system improves the quality and reliability of clinical annotations.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Editorial Material Pharmacology & Pharmacy

Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene Variation

Andrea Gaedigk et al.

Summary: PharmVar, founded in 2017, has provided the research and clinical pharmacogenetics/genomics communities with essential information on flagship pharmacogenes such as CYP2C9, CYP2C19, and CYP2D6 for the past four years. The consortium highlights recent milestones and standardization efforts in this Perspective.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Cell Biology

Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data

Maaike van der Lee et al.

Summary: The study introduces a proof-of-concept approach using continuous-scale assignments to predict CYP2D6 enzyme activity, showing potential for more accurate prediction of individual drug response compared to conventional *-allele approach. This model, trained with complete CYP2D6 gene sequences and tamoxifen metabolism data, explained a higher percentage of interindividual variability in enzyme activity and demonstrated advantages in predicting known and novel allele combinations.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Review Pharmacology & Pharmacy

Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

Alireza Tafazoli et al.

Summary: Pharmacogenomics (PGx) utilizes genetic data to optimize drug therapy, with next-generation sequencing (NGS) emerging as a more comprehensive and cost-effective approach. The advantages and challenges of implementing NGS-based tests in PGx are discussed, along with solutions for managing these technologies in clinical practice.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Pharmacogenomics Clinical Annotation Tool (PharmCAT)

Katrin Sangkuhl et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Rethinking the ethical principles of genomic medicine services

Stephanie B. Johnson et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Targeted nanopore sequencing with Cas9-guided adapter ligation

Timothy Gilpatrick et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study

Cathelijne H. van der Wouden et al.

PHARMACOGENETICS AND GENOMICS (2020)

Add to Collection

Article Pharmacology & Pharmacy

Pan-cancer pharmacogenetics: targeted sequencing panels or exome sequencing?

Laurentijn Tilleman et al.

PHARMACOGENOMICS (2020)

Add to Collection

Article Biochemical Research Methods

Transfer learning enables prediction of CYP2D6 haplotype function

Gregory McInnes et al.

PLOS COMPUTATIONAL BIOLOGY (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Best practices for benchmarking germline small-variant calls in human genomes

Peter Krusche et al.

NATURE BIOTECHNOLOGY (2019)

Add to Collection

Article Pharmacology & Pharmacy

Contemporary pharmacogenetic assays in view of the PharmGKB database

Laurentijn Tilleman et al.

PHARMACOGENOMICS (2019)

Add to Collection

Article Pathology

Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles A GeT-RM Collaborative Project

Andrea Gaedigk et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2019)

Add to Collection

Article Pharmacology & Pharmacy

Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and detection of duplications

Yusmiati Liau et al.

PHARMACOGENOMICS (2019)

Add to Collection

Article Biochemical Research Methods

Minimap2: pairwise alignment for nucleotide sequences

Heng Li

BIOINFORMATICS (2018)

Add to Collection

Editorial Material Pharmacology & Pharmacy

Accurately genotyping CYP2D6: not for the faint of heart

Charity Nofziger et al.

PHARMACOGENOMICS (2018)

Add to Collection

Article Multidisciplinary Sciences

Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes

Ibrahim Numanagic et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Article Pharmacology & Pharmacy

The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database

Andrea Gaedigk et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)

Add to Collection

Article Pathology

Preemptive Pharmacogenomic Testing for Precision Medicine A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade

Yuan Ji et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2016)

Add to Collection

Article Pathology

Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes A GeT-RM Collaborative Project

Victoria M. Pratt et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2016)

Add to Collection

Article Multidisciplinary Sciences

Pitfalls of haplotype phasing from amplicon-based long-read sequencing

Thomas W. Laver et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Biochemistry & Molecular Biology

The NIH genetic testing registry: a new, centralized database of genetic tests to enable access to comprehensive information and improve transparency

Wendy S. Rubinstein et al.

NUCLEIC ACIDS RESEARCH (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.